BALAXIBALAXI PHARMACEUTICALS LIMITED

Pharma · Drug Manufacturers - Specialty & Generic · NSE

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

₹—

—

Mkt Cap

₹132 Cr

P/E

91.9

P/B

0.5

Div Yield

0.00%

52W High

—

52W Low

—

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)131.90

P/E91.92

P/B0.53

PEG—

ROE %0.59

ROCE %2.10

Debt / Equity0.23

EPS0.26

Revenue Growth %-7.30

Profit Growth %-92.90

Dividend Yield %0.00

Promoter Holding %—

FII Holding %—

DII Holding %—

Beta0.70

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on BALAXI — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.